Having a genetic predisposition to insulin deficiency and abnormal fat distribution around the body may explain why South Asian people seem to be at particularly high risk for early onset type 2 diabetes, shows new U.K. research. Current estimates suggest around 10% of adults between the age of 20 and…

Diabetes rates have doubled worldwide over the last 30 years, according to a new report from the NCD Risk Factor Collaboration (NCD-RisC), with global prevalence rates rising from around 7% to 14%. The team also found that over half of adults with diabetes, mainly in lower- and middle-income countries, weren’t…

Research lead by Northwestern University in Chicago shows that people with chronic kidney disease and type 2 diabetes are at significantly increased risk of earlier heart disease. The research, which will be presented at the American Heart Association’s Scientific Sessions 2024 later this week by Vaishnavi Krishnan, a researcher at…

When compared to seven other anti-diabetic drugs, semaglutide may significantly lower the risk of Alzheimer’s disease in people with type 2 diabetes, according to new research from the Case Western Reserve School of Medicine. These results, which were based on data from a national health records database, were consistent across…

Ten to nineteen year olds had a 55% higher risk of a new type 2 diabetes (T2D) diagnosis one month after a COVID infection, compared with young people diagnosed with a non-COVID respiratory virus. The risk of TD2 diagnosis remained elevated at three months and six months, according to a…

A recent study from researchers in South Korea contends that certain diabetes medications known as sodium-glucose cotransporter-2 (SGLT2) inhibitors may be linked to a reduced risk of developing dementia and Parkinson’s disease. The findings, published this week in the journal Neurology, are significant given the rising prevalence of these neurodegenerative…

The Keck School of Medicine of USC has announced the launch of a nationwide longitudinal study aimed at understanding how type 1 diabetes impacts brain development in children. Funded by a $2.7 million grant from the National Institutes of Health, this multi-site study will involve collaboration among 12 research centers…

Patients with diabetes, especially type 1, have higher rates of sudden cardiac death (SCD), according to a study that used a nationwide Danish database. The work was led by Jacob Tfelt-Hansen, MD, of the University of Copenhagen. Tfelt-Hansen presented the findings at the European Society of Cardiology (ESC) Congress 2024.…

Research led by the Steno Diabetes Center Odense shows that high levels of interleukin (IL)-6 predicted increased risk for obesity-related cancer in newly diagnosed people with type 2 diabetes. Notably, other markers of inflammation, tumor necrosis factor-alpha (TNF-alpha) and high sensitivity C-reactive protein (hsCRP), did not significantly predict cancer risk…

There is a team readily available to report 24/7 to a facility at the University of Chicago Medical Center to quickly receive and process a deceased donor’s pancreas into isolated islets for infusion into a patient with type 1 diabetes. The results have been astounding. Some patients who underwent allogeneic…

A large Danish study led by Odense University suggests women who experience gestational diabetes are not at increased risk of breast cancer compared with the general population. Although gestational diabetes resolves after birth, women who have had the condition are known to be at higher risk of developing type 2…

Analyzing PET/CT scans using deep learning algorithms to evaluate images can help identify people at risk of developing type 2 diabetes, according to a study published today in the journal Radiology. The study of more than 32,000 people over the age of 25 in Korea, highlights the value of so-called…

Research led by Helmholtz Munich in Germany showed COVID-19 infection in high-risk young people almost doubled the rate of progression to type 1 diabetes during the pandemic compared with those who were not infected with the virus. The pandemic showed that COVID-19 increased the risk of diabetes. A systemic review…

A study of more than 1.5 million people with type 2 diabetes has shown that individuals using glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have a significantly lower risk for obesity-associated cancers (OACs) than those using insulin. The findings “provide preliminary evidence of the potential benefit of GLP-1 RAs for cancer…

While semaglutide has been in the biopharma limelight for its impressive effects on weight loss in adults with and without type 2 diabetes, it looks like it could soon be playing second fiddle to another glucagon-like peptide 1 GLP-1 receptor agonist-based medication when it comes to weight loss. A study…